Emergency: 9111-800-SILVARIS
Contact Us
← Patient Stories
Sandra Clark

Sandra Clark

Papillary thyroid carcinoma, classical variant, presenting as a solitary 2.8 cm thyroid nodule with fine-needle aspiration cytology Bethesda category V (suspicious for malignancy). Staging investigations showed no evidence of lymph node involvement or distant metastasis. Sandra underwent total thyroidectomy with central neck dissection, followed by post-operative radioactive iodine ablation therapy and initiation of TSH-suppressive levothyroxine therapy. Histopathology confirmed pT2N0 papillary thyroid carcinoma with clear surgical margins.

Sandra Clark discovered the lump in her neck while applying moisturiser on a Sunday morning. She was fifty-five, recently retired, and had been looking forward to a period of calm after decades of demanding work as a hospital administrator. The GP she saw that week was appropriately concerned and referred her urgently for ultrasound and biopsy. Fine needle aspiration cytology returned a result suspicious for malignancy. Thyroid cancer. Sandra was referred to the endocrine surgery service at Silvaris University Hospital in Boston, where she met the consultant endocrine surgeon who would perform her operation.

Her surgical team was thorough in its assessment. Staging scans showed the cancer appeared to be confined to the thyroid without lymph node spread — the best possible finding given the diagnosis. Her surgeon explained the planned operation: total thyroidectomy with clearance of the central neck lymph node compartment, followed by radioactive iodine treatment to ablate any remaining thyroid tissue and detect occult metastatic disease. He was honest about the key risks — a small risk of damage to the parathyroid glands and the recurrent laryngeal nerves, which could affect calcium regulation and voice respectively. 'He took the risk seriously,' Sandra says. 'He didn't minimise it. But he also explained that in experienced hands the risk was low, and I could tell I was in experienced hands.'

The thyroidectomy lasted three hours and was technically straightforward. Sandra woke with a neat transverse incision across the base of her neck and, most importantly, a voice that was clear and normal. Her calcium levels were monitored carefully in the post-operative period, and a short course of calcium supplementation was prescribed when they dipped slightly in the first week — a common and manageable complication that resolved fully within a month. Histopathology confirmed what imaging had suggested: papillary carcinoma confined to the thyroid with clear margins and no lymph node involvement. Her endocrine team described the prognosis as excellent.

Radioactive iodine treatment was administered as a day procedure six weeks after surgery. Sandra was required to follow a low-iodine diet in the weeks beforehand — a regimen that her endocrinologist's team made manageable with a detailed dietary guide and direct telephone access for questions. The treatment itself was straightforward, involving a single capsule and a day of isolation at home while the radiation dose fell to safe levels. Post-treatment scanning confirmed no distant metastatic disease. Levothyroxine was prescribed at a slightly higher than replacement dose to suppress TSH and reduce the stimulus for any residual thyroid cells to grow, a strategy Sandra now understands and manages confidently.

Four years after her diagnosis, Sandra is entirely well. Her annual thyroglobulin levels remain undetectable, and her annual neck ultrasound shows no evidence of recurrent disease. She manages her levothyroxine dose, attends annual endocrinology review, and has adapted fully to life without a thyroid gland. 'I was terrified when I heard the word cancer,' she says. 'But the team put it in context immediately. They explained that this was one of the most treatable cancers that exists, and that with the right treatment, the expectation was cure. That framing mattered enormously.' Sandra now volunteers at the hospital's patient information library, helping newly diagnosed thyroid cancer patients access the resources that supported her.

Treating Providers